BeiGene to open new site at Princeton, New Jersey

Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines

Catalent to further expand Galapagos’ decentralized CAR-T manufacturing network in US

New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience

Suven to acquire 56% stake in ADC specialist NJ Bio for US$64.4 million

This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape

Enzene appoints new site lead of biologics manufacturing

He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site

Benvic acquires specialty U.S. compounder Chemres

The ninth acquisition since 2018

Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent

Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction

Thermo Fisher opens biologics site in Lengnau, Switzerland

The state-of-the-art facility provides a pathway from development to large-scale biologics production

Machine Learning to understand and prevent disease

Barbara Engelhardt moves her computational and statistics lab to Gladstone

TAKE divests stake in Navitas Life Sciences to HIG

The transaction is expected to close in the Q4FY22